| 摘要 |
The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug (e.g. a monoclonal antibody, or fragment or derivative thereof), said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2 - 6 C-Atoms, or at least one salt thereof. |
